• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

EMD Serono

visual of a parachute
Biotech

AI firm Xaira powers up C-suite with pharma vet—Chutes & Ladders

AI firm Xaira powers up C-suite with pharma vet. Genesis shakes up leadership to advance AI platform. Restructuring Carisma cuts execs loose.
Darren Incorvaia , Zoey Becker Dec 13, 2024 8:30am
Photo from a distance of a parachute pulled by a boat

EMD Serono taps new COO—Chutes & Ladders

Jul 7, 2023 9:30am
Merck of Germany

Merck KGaA pays Aqilion €10M to tackle tough autoimmune target

Feb 16, 2023 6:00am
photo of the exterior of EMD Serono

Merck KGaA shrinks US R&D team as layoffs batter industry

Jan 23, 2023 10:00am
Missed target failed trial trial failure

Deeming success unlikely, Merck KGaA cuts lung cancer trial

Jun 3, 2022 11:51am
Merck kgaa

Merck KGaA pharma CEO reflects on I-O bispecific flop

Feb 16, 2022 10:40am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings